Treatment of Hypertension in Primary Care in Spain (TAPAS)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00868881
First received: March 24, 2009
Last updated: July 10, 2009
Last verified: July 2009
  Purpose

Non-interventional,observational and retrospective study assessing the therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control.


Condition
Hypertension

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Treatment of Hypertension in Primary Care in Spain

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control. [ Time Frame: 1 Year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Variation in the Percentage of patients with blood pressure controlled and not controlled during a year of follow-up. [ Time Frame: 1 Year ] [ Designated as safety issue: No ]
  • Clinical profile and cardiovascular risk. [ Time Frame: 1 Year ] [ Designated as safety issue: No ]

Estimated Enrollment: 2160
Study Start Date: March 2009
Study Completion Date: July 2009
Groups/Cohorts
1
Blood Pressure poorly controlled in the previous year and poorly controlled at the inclusion in the study
2
Blood Pressure poorly controlled in the previous year and well controlled at the inclusion in the study.
3
Blood Pressure well controlled in the previous year and well controlled at the inclusion in the study
4
Blood Pressure well controlled in the previous year and poorly controlled at the inclusion in the study
5
Blood Pressure well controlled in the previous year independently of the level of control at the inclusion.
6
Blood Pressure poorly controlled in the previous year independently of the level of control at the inclusion.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients aged 18 years or older who has been diagnosed of primary hypertension and/or treated for hypertension.

Criteria

Inclusion Criteria:

  • Diagnosis of primary hypertension and/or treated for hypertension for one year or more
  • Clinical data of blood pressure measures for the last 12+/- 2 months before inclusion.

Exclusion Criteria:

  • Secondary Hypertension
  • Physical or psychological impairment for the understanding of the information to be given to the patient
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00868881

  Show 167 Study Locations
Sponsors and Collaborators
AstraZeneca
  More Information

No publications provided

Responsible Party: Juan Carlos Palma, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00868881     History of Changes
Other Study ID Numbers: NIS-CES-DUM-2008/2
Study First Received: March 24, 2009
Last Updated: July 10, 2009
Health Authority: Spain: Ethics Committee

Keywords provided by AstraZeneca:
Hypertension
Therapeutic diagnostic attitude
Blood pressure

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 14, 2014